@article{ref1,
title="Melatonin treatment in adolescents with delayed sleep phase syndrome",
journal="Clinical pediatrics",
year="2006",
author="Szeinberg, Amir and Borodkin, Katy and Dagan, Yaron",
volume="45",
number="9",
pages="809-818",
abstract="This retrospective study describes the effects of long-term treatment with melatonin in 33 adolescents (age range, 10-18 years) with delayed sleep phase syndrome (DSPS). Patients were treated with oral melatonin, 3 to 5 mg/day for an average period of 6 months. During the treatment, sleep onset was advanced and sleep duration was longer. Treatment was also associated with a decrease in the proportion of patients reporting school difficulties. No adverse effects of melatonin were noted. This study indicates that long-term treatment with melatonin can be beneficial for adolescents with DSPS in terms of sleep-wake schedule and school performance.<p /><p>Language: en</p>",
language="en",
issn="0009-9228",
doi="10.1177/0009922806294218",
url="http://dx.doi.org/10.1177/0009922806294218"
}